Buy One Get One free -Llimited Time Offer X
Metformin + Teneligliptin is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Metformin + Teneligliptin safe for pregnant women?
Metformin + Teneligliptin can have harmful effects in pregnant women. If you experience any discomfort after using Metformin + Teneligliptin, then discontinue the use and take your doctor's advice.
Is the use of Metformin + Teneligliptin safe during breastfeeding?
Metformin + Teneligliptin may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Metformin + Teneligliptin on the Kidneys?
There is no research available on the side effects of Metformin + Teneligliptin on kidney. Therefore, its impact is unknown.
What is the effect of Metformin + Teneligliptin on the Liver?
Side effects of Metformin + Teneligliptin on the liver are unknown because research on this has not been conducted yet.
What is the effect of Metformin + Teneligliptin on the Heart?
There is no research available on the side effects of Metformin + Teneligliptin on the heart. Therefore, its impact is unknown.
Metformin + Teneligliptin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Metformin + Teneligliptin unless your doctor advises you to do so -
Is this Metformin + Teneligliptin habit forming or addictive?
No, there is no any evidence that Metformin + Teneligliptin is addictive.
Interaction between Food and Metformin + Teneligliptin
There is no information on the effects of taking Metformin + Teneligliptin with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Metformin + Teneligliptin
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Metformin + Teneligliptin.
Yes, Metformin + Teneligliptin commonly cause stomach upset like diarrhea, abdominal pain, nausea, and vomiting. To avoid these side effects you should take Metformin + Teneligliptin with your meal and increase the dose gradually.
Metformin + Teneligliptin contain metformin, is an oral antidiabetic drug which belongs to the class of biguanide. It is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polycystic ovary syndrome. Moreover, it also reduces the risk of cardiovascular complications of diabetes.
Yes, Metformin + Teneligliptin is safe to use, many people have side effects at first, they usually diminish and then go away completely in a few weeks. A few people find they cannot tolerate metformin, there are other drugs but metformin is usually the first choice. It is very safe
Metformin + Teneligliptin helps in weight loss by reducing appetite and food intake. It also increases the insulin sensitivity in your body to work more effectively. This lead to decreased glucose production increases the use of glucose and decrease the fat deposition further helps in weight loss. However, Metformin + Teneligliptin is not approved for weight loss, this is an off-label use.
Metformin + Teneligliptin is not a known cause of alopecia (hair loss). However, the conditions treated by Metformin + Teneligliptin type 2 diabetes and PCOS, often list hair loss as a possible symptom.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826